According to the bulletin of the State Intellectual Property Office, the patent application for the new crown vaccine jointly applied by Chen Wei, academician team of Academy of military medicine, Academy of Military Sciences and kangxinuo biology has been granted patent right, which is the first patent of new crown vaccine in China.

The vaccine is called novel coronavirus vaccine with human replication defective adenovirus as the carrier, which is an adenovirus vector vaccine developed by Chen Wei's team (Ad5-nCoV vaccine). The novel coronavirus vaccine is a human type 5 replication defective adenovirus vector, according to the patent summary.

The vaccine has good immunogenicity in mice and guinea pigs, and can induce strong cellular and humoral immune responses in a short time. In addition, the preparation of the vaccine is rapid and simple, and can be used in large-scale production in a short period of time to deal with sudden outbreaks.

On August 11, 2020, academician Chen Wei was awarded the national honorary title of "people's hero".

[warm tips] source: Internet. The copyright belongs to the original author. If there is something wrong, please contact to inform us of modification or deletion. Thank you.